Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance Evaluation of the Biological Diagnosis of Heparin-induced Thrombocytopenia (HIT)

NCT06180785 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT06180785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06180785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance Evaluation of the Biological Diagnosis of Heparin-induced Thrombocytopenia (HIT)
Lead sponsor
University Hospital, Strasbourg, France
Phase
Observational
Overall status
Unknown status
Start date
June 27, 2022
Completion date
December 31, 2023
Enrollment
894 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heparin-induced thrombocytopenia (hit)